Assessment of Circulating Tumor Cells and Serum Markers for Progression-free Survival Prediction in Metastatic Breast Cancer: a Prospective Observational Study

被引：0
|
作者：
Pierga, J. Y. [1 ]
Hajage, D. [2 ]
Bachelot, T. [3 ]
Delaloge, S. [4 ]
Brain, E. [5 ]
Campone, M. [6 ]
Cottu, P. H. [1 ]
Beuzeboc, P. [1 ]
Rolland, E. [2 ]
Bidard, F. C. [1 ]
机构：
[1] Inst Curie, Dept Med Oncol, Paris, France
[2] Inst Curie, Dept Biostat, Paris, France
[3] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[4] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[5] Inst Curie, Dept Med Oncol, St Cloud, France
[6] Inst Cancerol Ouest, Nantes, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [31] Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
    Matsubara, Yoshihiro
    Sakabayashi, Satomi
    Nishimura, Tsutomu
    Ishida, Takanori
    Ohuchi, Noriaki
    Teramukai, Satoshi
    Fukushima, Masanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 623 - 629
  • [32] Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
    Madhavan, Dharanija
    Zucknick, Manuela
    Wallwiener, Markus
    Cuk, Katarina
    Modugno, Caroline
    Scharpff, Martina
    Schott, Sarah
    Heil, Joerg
    Turchinovich, Andrey
    Yang, Rongxi
    Benner, Axel
    Riethdorf, Sabine
    Trumpp, Andreas
    Sohn, Christof
    Pantel, Klaus
    Schneeweiss, Andreas
    Burwinkel, Barbara
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5972 - 5982
  • [33] Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
    Zubritsky, Lindsey
    Leitzel, Kim
    Ali, Suhail M.
    Kstler, Wolfgang
    Fuchs, Eva-Maria
    Costa, Luis
    Knight, Robert D.
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [34] Association of inflammatory and tumor markers with circulating tumor cells in metastatic breast cancer
    Lohmann, A. E.
    Chang, M.
    Dowling, R. J. O.
    Ennis, M.
    Amir, E.
    Elser, C.
    Brezden-Masley, C.
    Vandenberg, T.
    Lee, E.
    Fazae, K.
    Stambolic, V.
    Goodwin, P. J.
    CANCER RESEARCH, 2016, 76
  • [35] Estimating changes in overall survival using progression-free survival in metastatic breast and colorectal cancer
    Bowater, Russell J.
    Lilford, Philippa E.
    Lilford, Richard J.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (03) : 207 - 214
  • [36] A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer
    Burzykowski, T
    Piccart, MJ
    Sledge, G
    Carmichael, J
    Luck, HJ
    Mackey, JR
    Nabholtz, JM
    Paridaens, R
    Biganzoli, L
    Jassem, J
    Blohmer, JU
    Bontenbal, M
    Bonneterre, J
    Chan, S
    Atalay, G
    Therasse, P
    Buyse, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S277 - S278
  • [37] Relevance of circulating tumor cells (CTC) in the progression of metastatic breast cancer
    Altimari, A.
    Quercia, S.
    Benedettini, E.
    Rosati, M.
    Capizzi, E.
    Bernardi, A.
    Fiorentino, M.
    Zamagni, C.
    Grigioni, A. D'Errico
    Martoni, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole
    Behrouzi, R.
    Moon, S.
    Eaton, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S507 - S507
  • [39] Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
    Sara A. Hurvitz
    Deepa Lalla
    Ross D. Crosby
    Susan D. Mathias
    Breast Cancer Research and Treatment, 2013, 142 : 603 - 609
  • [40] Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
    Hurvitz, Sara A.
    Lalla, Deepa
    Crosby, Ross D.
    Mathias, Susan D.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 603 - 609
12345